Stock Information
Ultragenyx Pharmaceutical Inc (RARE)
Ticker Symbol: RARE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,165.92 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -5.8324
Revenue (TTM): $6.74 M
Dividend Yield: N/A%
ROE: -414.17%
Latest News
-
Morgan Stanley Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $67
Thu, Apr 16, 2026 12:40 PM
-
Ultragenyx Pharmaceutical: The Market Is Overlooking 2026 Catalysts
Sun, Apr 12, 2026 8:47 AM
Key Financials
Financial data not available